Please wait a minute...
文章检索
预防医学  2020, Vol. 32 Issue (4): 361-365    DOI: 10.19485/j.cnki.issn2096-5087.2020.04.009
  综述 本期目录 | 过刊浏览 | 高级检索 |
新型冠状病毒实验室检测方法研究进展
张友春1,汪睿2综述,朱永良2审校
1.淳安县妇幼保健院,浙江 淳安 311700;
2.浙江大学医学院附属第二医院
Research progress of laboratory testing methods for SARS-CoV-2
ZHANG Youchun*, WANG Rui, ZHU Yongliang
*Maternal and Child Health Hospital of Chun'an,Chun'an,Zhejiang 311700,China
全文: PDF(633 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 新型冠状病毒(SARS-CoV-2)正在世界范围内暴发流行,导致人类严重呼吸道疾病且致死率高,引起全球的高度关注。该病毒造成的新型冠状病毒肺炎(COVID-19)尚无特效治疗药物,早期诊断是当前主要的防控措施。依据《新型冠状病毒肺炎诊疗方案(试行第七版)》,病毒核酸检测阳性、基因测序高度同源或血清学抗体检测阳性均可确诊SARS-CoV-2感染,然而各种检测方法均存在一定的假阴性率和潜在的假阳性结果。本文对目前正在应用和报道的SARS-CoV-2实验室检测方法,如病毒分离、二代测序技术、反转录-聚合酶链式反应、恒温核酸扩增技术、基因芯片和抗体检测等进行综述,并探讨各种方法的优缺点,为优化SARS-CoV-2感染诊断提供参考。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
ZHANG Youchun
WANG Rui
ZHU Yongliang
关键词 新型冠状病毒病毒分离核酸检测抗体检测    
Abstract:The outbreak of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)all over the world leads to serious respiratory diseases and high mortality,which arouses wide concern. No specific treatment for coronavirus disease 2019(COVID-19)caused by the virus has been found,so early diagnosis is the main prevention and control measure at present. According to the COVID-19 Diagnosis and Treatment Plan(Seventh Trial),Being positive in nucleic acid testing or in antibody testing,or being highly homologous in gene sequencing can confirm SARS-CoV-2 infection. However, all these detection Methods have potential false negative and false positive Results. This article summarizes the SARS-CoV-2 laboratory testing Methods that are being applied and studied at present,such as virus isolation,second generation sequencing,reverse transcription-polymerase chain reaction,nucleic acid isothermal amplification,gene chip and antibody detection,and discusses their advantages and disadvantages to optimize the diagnosis of SARS-CoV-2 infection.
Key wordssevere acute respiratory syndrome coronavirus 2    virus isolation    nucleic acid detection    serological detection
收稿日期: 2020-03-01      修回日期: 2020-03-17      出版日期: 2020-04-10
中图分类号:  R446  
  R563.1  
通信作者: 朱永良,E-mail:ylzhu@zju.edu.cn   
作者简介: 张友春,本科,副主任检验师,主要从事临床检验工作
引用本文:   
张友春,汪睿 综述,朱永良 审校. 新型冠状病毒实验室检测方法研究进展[J]. 预防医学, 2020, 32(4): 361-365.
ZHANG Youchun, WANG Rui, ZHU Yongliang. Research progress of laboratory testing methods for SARS-CoV-2. Preventive Medicine, 2020, 32(4): 361-365.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2020.04.009      或      http://www.zjyfyxzz.com/CN/Y2020/V32/I4/361
[1] ZHU N, ZHANG D,WANG W, et al.A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020, 382(8): 727-733.
[2] GORBALENYA A E,BAKER S C, BARIC R S, et al. Severe acute respiratory syndrome-related coronavirus:the species and its viruses-a statement of the Coronavirus Study Group [J/OL]. BioRxiv(2020-02-07)[2020-03-17].https://doi.org/10.1101/
2020.02.07.937862.
[3] TO K K, TSANG O T,CHIK-YAN YIP C,et al. Consistent detection of2019 novel coronavirus in Saliva [J/OL]. Clin Infect Dis(2020-02-12)[2020-03-17]. https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/ciaa149.
[4] HANG W,DU R H, LI B,et al.Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes[J]. Emerg Microbes Infect, 2020, 9(1): 386-389.
[5] XIA J, TONG J,LIU M,et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection [J]. J Med Virol(2020-02-26)[2020-03-17]. https://doi.org/10.1002/jmv.25725.
[6] 邓少丽,刘丁.新型冠状病毒肺炎的实验室分子诊断及生物安全刍识[J/OL].国际检验医学杂志[2020-03-17].http://kns.cnki.net/kcms/detail/50.1176.R.20200310.0935.002.html.
[7] 刘焱斌,刘涛,崔跃,等. 鼻拭子与咽拭子两种取样方法在新型冠状病毒核酸筛检中的比较研究 [J/OL] 中国呼吸与危重监护杂志,2020(2020-03-02)[2020-03-17].http://kns.cnki.net/kcms/detail/51.1631.R.20200228.1506.004.html.
[8] YANG Y,YANG M H, SHEN C G,et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of2019-nCoV infections[J]. medRxiv[2020-03-17].https://doi.org/10.1101/2020.02.11.20021493.
[9] 中华人民共和国国家卫生健康委员会办公厅.新型冠状病毒感染的肺炎实验室检测技术指南(第四版)[EB/OL].(2020-02-06) [2020-03-17].http://www.nhc.gov.n/jkj/s3577/202002/573340613cab 243b3a7f61df260551dd4.shtml.
[10] 张欢,郑焕英,邹丽容,等. 广东省首例新型冠状病毒的分离与鉴定 [J/OL]. 病毒学报,2020(2020-03-05 )[2020-03-17]https://doi.org/10.13242/j.cnki.bingduxuebao.003657.
[11] 许金和, 王水良, 张胜行,等. 新型冠状病毒核酸检测方法 [J/OL]. 国际检验医学杂志, 2020(2020-03-03)[2020-03-17].http://kns.cnki.net/kcms/detail/50.1176.R.20200303.1428.002.html.
[12] LU R, ZHAO X,LI J,et al.Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding[J]. Lancet, 2020, 395(10224): 565-574.
[13] WANG M, FU A, HU B,et al. Nanopore target sequencing for accurate and comprehensive detection of SARS-CoV-2 and other respiratory viruses[EB/OL].(2020-03-04)[2020-03-17].https://doi.org/10.1101/2020.03.04.20029538.
[14] 鲁彦, 居军, 李德红. 核酸和血清学指标结合,多类型联检,提高新型冠状病毒检出率 [J/OL]. 检验医学与临床, 2020(2020-03-10)[2020-03-17].http://www.nhc.gov.cn/jkj/s3577/202002/573340613ab243b3a7f61df260551dd4/files/c791e5a7ea5149f680fdcb34dac0f54e.pdf.
[15] 郭晓波,蔺京,来春艳,等. 新型冠状病毒与实时荧光RT-PCR核酸检测[J]. 陕西医学杂志,2020,49(3):264-266.
[16] 梁海燕,刘文鑫,杨志刚. 等温核酸扩增技术进展[J]. 中国医学创新,2017,14(16):145-148.
[17] CHEN C M, OUYANG S, LIN L Y, et al. Diagnostic accuracy of LAMP assay for HBV infection [J/OL]. J Clin Lab Anal(2020-03-10)[2020-03-17].https://doi.org/10.1002/jcla.23281.
[18] HUANG P, WANG H, CAO Z, et al.A rapid and specific assay for the detection of MERS-CoV[J]. Front Microbiol, 2018, 9:1101-1109.
[19] KEIGHTLEY M C, SILLEKENS P, SCHIPPERS W, et al.Real-time NASBA detection of SARS-associated coronavirus and comparison with real-time reverse transcription-PCR[J]. J Med Virol, 2005, 77(4): 602-608.
[20] 高闪电, 常惠芸, 丛国正,等. NASBA(依赖核酸序列的扩增)技术及其在病毒检测中的应用[J]. 中国生物工程杂志, 2009,29(1): 80-85.
[21] WANG B, POTTER S J, LIN Y, et al.Rapid and sensitive detection of severe acute respiratory syndrome coronavirus by rolling circle amplification[J]. J Clin Microbiol,2005, 43(5): 2339-2344.
[22] WANG D, URISMAN A, LIU Y T, et al.Viral discovery and sequence recovery using DNA microarrays[J]. PLoS Biol, 2003, 1(2): E2.
[23] CaptitalBio Corporation.CapitalBio Respiratory Virus Nucleic Acid Detection Kit[EB/OL].[2020-03-17]. http://www.capitalbio.com/diagnostic/tbrelatedkits/identificationarray/RePaKit/28042.shtml.
[24] JUANG J L, CHEN T C, JIANG S S, et al.Coupling multiplex RT-PCR to a gene chip assay for sensitive and semiquantitative detection of severe acute respiratory syndrome-coronavirus[J]. Lab Invest, 2004, 84(9): 1085-1091.
[25] GUO X, GENG P, WANG Q, et al.Development of a single nucleotide polymorphism DNA microarray for the detection and genotyping of the SARS coronavirus[J]. J Microbiol Biotechnol, 2014, 24(10): 1445-1454.
[26] 罗效梅, 王静, 张娅,等. 全血SARS-CoV-2特异性抗体检测对2019-冠状病毒病的临床应用价值分析 [J/OL]. 西南大学学报(自然科学版)(2020-09-09)[2020-03-17].http://kns.cnki.net/kcms/detail/50.1189.N.20200306.1716.004.html.
[27] 中华人民共和国国家卫生健康委员会办公厅,中华人民共和国国家中医药管理局办公室.关于印发新型冠状病毒肺炎诊疗方案(试行第七版)的通知[EB/OL].(2020-03-04)[2020-03-17].http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.
[28] LI Z, YI Y, LUO X, et al. Development and clinical application of arapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis [J/OL]. J Med Virol, 2020(2020-02-27)[2020-03-17].https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25727.
[29] 马建, 贺鹏飞, 赵晨燕,等. SARS和MERS中和抗体假病毒检测方法的建立[J]. 病毒学报, 2019, 35(2): 189-195.
[30] 薛雄燕, 朱嫦琳, 黄少珍,等. 灭活血液样本对不同方法检测2019新型冠状病毒抗体检测结果的影响 [J/OL]. 南方医科大学学报, 2020(2020-03-02)[2020-03-17].http://kns.cnki.net/kcms/detail/44.1627.R.20200228.1733.002.html.
[31] 邹明园,吴国球. 抗原交叉反应对新型冠状病毒血清特异性抗体检测的影响[J]. 临床检验杂志, 2020: 1-3.
[32] CHE X Y, HAO W, WANG Y, et al.Nucleocapsid Protein as Early Diagnostic Marker for SARS[J]. Emerg Infect Dis, 2004, 10(11):1947-1949.
[33] CHEN Y, CHAN K H, KANG Y, et al.A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus[J]. Emerg Microbes Infect, 2015, 4(4): e26.
[34] 鲍春梅,李波, 王欢, 等. 新型冠状病毒的实验室生物风险评估与风险控制[J]. 传染病信息, 2020, 33(1): 90-95.
[1] 柏建芸, 赵芳凝, 候金余, 郭燕, 郑敏娜, 李龙, 于茂河. 2005—2021年天津市医疗机构HIV/AIDS检测发现情况分析[J]. 预防医学, 2023, 35(6): 475-479.
[2] 段恬筱, 黄希汇, 刘诗川, 胡薇薇, 刘涛, 李亚, 岑斌. 新型冠状病毒感染流行期间医护人员职业倦怠的Meta分析[J]. 预防医学, 2023, 35(6): 526-532.
[3] 周嘉昱, 施剑飞. 新型冠状病毒感染疫情期间医护人员心理问题及干预研究进展[J]. 预防医学, 2023, 35(4): 307-310.
[4] 向泽林, 富小飞, 亓云鹏, 朱国英, 顾伟玲, 胡洁, 李傅冬, 周晚玲, 侯志刚, 刘杨, 刘砚清, 郭飞飞, 陆先权, 郭林杰, 陈中文. 羽毛球场馆一起新型冠状病毒感染聚集性疫情的流行病学调查[J]. 预防医学, 2023, 35(4): 316-319.
[5] 丰燕, 陈寅, 蔡剑, 潘金仁, 孙琬琬, 张严峻, 凌锋, 孙继民. 新型冠状病毒感染者血清中和抗体分析[J]. 预防医学, 2023, 35(2): 121-125.
[6] 罗西, 覃世龙, 明方钊, 余庆, 范传刚. 武汉市MSM人群HIV抗体重复检测的影响因素分析[J]. 预防医学, 2022, 34(8): 831-835.
[7] 沈强, 张月琴, 江圣洁, 甘露, 尉莹莹. 新冠肺炎疫情期间医务人员焦虑状况的Meta分析[J]. 预防医学, 2022, 34(7): 720-726.
[8] 陈剑, 任飞林, 郭聪聪, 林君芬. 接种新冠病毒疫苗意愿的影响因素分析[J]. 预防医学, 2022, 34(6): 611-615.
[9] 华倩慧, 徐校平, 吕华坤, 张杭杰, 蒋健敏. 特定人群接种新冠病毒疫苗的安全性和有效性研究进展[J]. 预防医学, 2022, 34(5): 479-482.
[10] 施长苗, 敖新华, 邵斌, 杨卫锋, 王伟洪, 童照威, 沈建勇, 余育晖. 入境人员集中隔离点新型冠状病毒核酸检测阳性病例特征分析[J]. 预防医学, 2022, 34(4): 325-329.
[11] 张栋梁, 易波, 陈奕, 胡群雄, 凌锋, 马晓, 雷松, 董红军, 倪红霞, 毛洋, 李巧方, 陈耀荣, 陆烨, 龚震宇, 蔡剑, 陈直平, 吕筠, 许国章. 一例海港口岸境外关联新型冠状病毒感染的流行病学调查[J]. 预防医学, 2022, 34(4): 380-384,388.
[12] 吴晨, 吴昊澄, 鲁琴宝, 丁哲渊, 王心怡, 傅天颖, 杨珂, 林君芬. 浙江省境外输入新型冠状病毒肺炎病例流行特征[J]. 预防医学, 2022, 34(12): 1245-1250.
[13] 王臻, 刘碧瑶, 戚小华, 张人杰, 边俏, 江敏. 浙江省新型冠状病毒肺炎本土感染者流行特征[J]. 预防医学, 2022, 34(12): 1240-1244.
[14] 徐娜妮, 胡小炜, 李海燕, 郑琳, 孔庆鑫, 覃盼, 李静, 叶非. 接种新型冠状病毒灭活疫苗血清抗体水平分析[J]. 预防医学, 2022, 34(1): 33-36,41.
[15] 祝宏, 董杰, 凌霞, 励晓涛, 吴丹霄, 朱发明. 杭州市无偿献血者乙型肝炎病毒感染及其传播残余风险分析[J]. 预防医学, 2022, 34(1): 63-65,69.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed